3D contrast-enhanced MR angiography

Journal of Magnetic Resonance Imaging

Volumn 25, Issue 1, 2007, Pages 13-25

  Zhang, HongLei ^a   Maki, Jeffrey H ^b   Prince, Martin R ^a,c,d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Columbia College of Physicians and Surgeons ^*  (United States)

^d NONE   (United States)

Author keywords

Atherosclerosis; Cardiovascular disease; Contrast enhanced; Gadolinium; MR angiography; Thigh compression

Indexed keywords

GADOLINIUM;

ARTIFACT; BOLUS INJECTION; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; FOURIER TRANSFORMATION; HUMAN; IMAGE QUALITY; IMAGE RECONSTRUCTION; IONIZING RADIATION; MAGNETIC RESONANCE ANGIOGRAPHY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REVIEW; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING; TIME; VASCULAR DISEASE;

ARTIFACTS; CONTRAST MEDIA; FOURIER ANALYSIS; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE ANGIOGRAPHY; VASCULAR DISEASES;

EID: 33846195472     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.20767     Document Type: Review

References (117)

1. Morcos SK, Thomsen HS, Webb JA. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee. European Society of Urogenital Radiology (ESUR). Eur Radiol 1999;9:1602-1613.
2. Dalla-Palma L, Panzetta G, Pozzi-Mucelli RS, Galli G, Cova M, Meduri S. Dynamic magnetic resonance imaging in the assessment of chronic medical nephropathies with impaired renal function. Eur Radiol 2000;10:280-286.
3. Townsend RR, Cohen DL, Katholi R et al. Safety of intravenous gadolinium (Gd-BOPTA) infusion in patients with renal insufficiency. Am J Kidney Dis 2000;36:1207-1212.
4. Erley CM, Bader BD, Berger ED, et al. Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients. Nephrol Dial Transplant 2004;19:2526-2531.
5. Hathout GM, Duh MJ, El-Saden SM. Accuracy of contrast-enhanced MR angiography in predicting angiographic stenosis of the internal carotid artery: linear regression analysis. AJNR Am J Neuroradiol 2003;24:1747-1756.
6. Serfaty JM, Chirossel P, Chevallier JM, Ecochard R, Froment JC, Douek PC. Accuracy of three-dimensional gadolinium-enhanced MR angiography in the assessment of extracranial carotid artery disease. AJR Am J Roentgenol 2000;175:455-463.
7. Prince MR, Narasimham DL, Stanley JC, et al. Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology 1995;197:785-792.
8. Siegelman ES, Gilfeather M, Holland GA, et al. Breath-hold ultrafast three-dimensional gadolinium-enhanced MR angiography of the renovascular system. AJR Am J Roentgenol 1997;168:1035-1040.
9. Ernst O, Asnar V, Sergent G, et al. Comparing contrast-enhanced breath-hold MR angiography and conventional angiography in the evaluation of mesenteric circulation. AJR Am J Roentgenol 2000;174:433-439.
10. Thornton J, O'Callaghan J, Walshe J, O'Brien E, Varghese JC, Lee MJ. Comparison of digital subtraction angiography with gadolinium-enhanced magnetic resonance angiography in the diagnosis of renal artery stenosis. Eur Radiol 1999;9:930-934.
11. Oudkerk M, van Beek EJ, Wielopolski P, et al. Comparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective study. Lancet 2002;359:1643-1647.
12. Hany TF, Debatin JF, Leung DA, Pfammatter T. Evaluation of the aortoiliac and renal arteries: comparison of breath-hold, contrast-enhanced, three-dimensional MR angiography with conventional catheter angiography. Radiology 1997;204:357-362.
13. Neimatallah MA, Ho VB, Dong Q, et al. Gadolinium-enhanced 3D magnetic resonance angiography of the thoracic vessels. J Magn Reson Imaging 1999;10:758-770.
14. Fain SB, King BF, Breen JF, Kruger DG, Riederer SJ. High-spatial- resolution contrast-enhanced MR angiography of the renal arteries: a prospective comparison with digital subtraction angiography. Radiology 2001;218:481-490.
15. Schoenberg SO, Rieger J, Weber CH, et al. High-spatial-resolution MR angiography of renal arteries with integrated parallel acquisitions: comparison with digital subtraction angiography and US. Radiology 2005;235:687-698.
16. Prince MR, Grist TM, Debatin JF. 3D contrast MR angiography. Berlin: Springer, 2003. p 6.
17. Chung T, Muthupillai R. Application of SENSE in clinical pediatric body MR imaging. Top Magn Reson Imaging 2004;15:187-196.
18. Fink C, Ley S, Kroeker R, Requardt M, Kauczor HU, Bock M. Time-resolved contrast-enhanced three-dimensional magnetic resonance angiography of the chest: combination of parallel imaging with view sharing (TREAT). Invest Radiol 2005;40:40-48.
19. Tsuchiya K, Honya K, Fujikawa A, Tateishi H, Shiokawa Y. Postoperative assessment of extracranial-intracranial bypass by time-resolved 3D contrast-enhanced MR angiography using parallel imaging. AJNR Am J Neuroradiol 2005;26:2243-2247.
20. Xu Y, Haacke EM. Partial Fourier imaging in multi-dimensions: a means to save a full factor of two in time. J Magn Reson Imaging 2001;14:628-635.
21. Hu HH, Madhuranthakam AJ, Kruger DG, Glockner JF, Riederer SJ. Combination of 2D sensitivity encoding and 2D partial fourier techniques for improved acceleration in 3D contrast-enhanced MR angiography. Magn Reson Med 2006;55:16-22.
22. Zaitsev M, Zilles K, Shah NJ. Shared k-space echo planar imaging with keyhole. Magn Reson Med 2001;45:109-117.
23. Bi X, Park J, Larson AC, Zhang Q, Simonetti O, Li D. Contrast-enhanced 4D radial coronary artery imaging at 3.0 T within a single breath-hold. Magn Reson Med 2005;54:470-475.
24. Park J, Larson AC, Zhang Q, Simonetti O, Li D. 4D radial coronary artery imaging within a single breath-hold: cine angiography with phase-sensitive fat suppression (CAPS). Magn Reson Med 2005;54:833-840.
25. Zhu H, Buck DG, Zhang Z, et al. High temporal and spatial resolution 4D MRA using spiral data sampling and sliding window reconstruction. Magn Reson Med 2004;52:14-18.
26. Wu YJ, Wu Y, Korosec FR, Wieben O, Du J, Mistretta CA. HYPR PR-TRICKS: Highly undersampled hybrid radial/Cartesian acquisition with highly constrained backprojection reconstruction for time resolved MRI. In: Proceedings of the 14th Annual Meeting of ISMRM. Seattle, WA. USA, 2006 (Abstract 74).
27. Mistretta CA, Wieben O, Velikina J, et al. Highly constrained backprojection for time-resolved MRI. Magn Reson Med 2006;55:30-40.
28. Wang Y, Johnston DL, Breen JF, et al. Dynamic MR digital subtraction angiography using contrast enhancement, fast data acquisition, and complex subtraction. Magn Reson Med 1996;36:551-556.
29. Wilman AH, Yep TC, Al-Kwifi O. Quantitative evaluation of non-repetitive phase-encoding orders for first-pass. 3D contrast-enhanced MR angiography. Magn Reson Med 2001;46:541-547.
30. Riederer SJ, Fain SB, Kruger DG, Busse RF. Real-time imaging and triggering of 3D contrast-enhanced MR angiograms using MR fluoroscopy. MAGMA 1999;8:196-206.
31. Wilman AH, Riederer SJ, King BF, Debbins JP, Rossman PJ, Ehman RL. Fluoroscopically triggered contrast-enhanced three-dimensional MR angiography with elliptical centric view order: application to the renal arteries. Radiology 1997;205:137-146.
32. Goldfarb JW, Prasad PV, Griswold MA, Edelman RR. Dynamic three-dimensional magnetic resonance abdominal angiography and perfusion: implementation and preliminary experience. J Magn Reson Imaging 2000;11:201-207.
33. Watts R, Wang Y, Redd B, et al. Recessed elliptical-centric view-ordering for contrast-enhanced 3D MR angiography of the carotid arteries. Magn Reson Med 2002;48:419-424.
34. Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR Am J Roentgenol 1984;142:619-624.
35. Herold T, Paetzel C, Volk M, et al. Contrast-enhanced magnetic resonance angiography of the carotid arteries: influence of injection rates and volumes on arterial-venous transit time. Invest Radiol 2004;39:65-72.
36. Ho VB, Corse WR. MR angiography of the abdominal aorta and peripheral vessels. Radiol Clin North Am 2003;41:115-144.
37. Knopp MV, Floemer F, Schoenberg SO, von Tengg-Kobligk H, Bock M, van Kaick G. Non-invasive assessment of renal artery stenosis: current concepts and future directions in magnetic resonance angiography. J Comput Assist Tomogr 1999;23(Suppl 1):S111-S117.
38. Krinsky G. Gadolinium-enhanced three-dimensional magnetic resonance angiography of the thoracic aorta and arch vessels. A review. Invest Radiol 1998;33:587-605.
39. Maki JH, Chenevert TL, Prince MR. Three-dimensional contrast-enhanced MR angiography. Top Magn Reson Imaging 1996;8:322-344.
40. Prince MR. Contrast-enhanced MR angiography: theory and optimization. Magn Reson Imaging Clin N Am 1998;6:257-267.
41. Rofsky NM. MR angiography of the aortoiliac and femoropopliteal vessels. Magn Reson Imaging Clin N Am 1998;6:371-384.
42. Schoenberg SO, Knopp MV, Bock M, Prince MR, Allenberg JR. Combined morphologic and functional assessment of renal artery stenosis using gadolinium enhanced magnetic resonance imaging. Nephrol Dial Transplant 1998;13:2738-2742.
43. Rieger J, Sitter T, Toepfer M, Linsenmaier U, Pfeifer KJ, Schiffl H. Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function. Nephrol Dial Transplant 2002;17:824-828.
44. Carroll TJ, Korosec FR, Swan JS, Hany TF, Grist TM, Mistretta CA. The effect of injection rate on time-resolved contrast-enhanced peripheral MRA. J Magn Reson Imaging 2001;14:401-410.
45. Schmidt MA, Britten AJ, Tomlinson MA, et al. Contrast-enhanced magnetic resonance angiography of the iliac arteries: optimization by injection simulation. Magn Reson Med 2001;46:365-373.
46. Shetty AN, Bis KG, Kirsch M, Weintraub J, Laub G. Contrast-enhanced breath-hold three-dimensional magnetic resonance angiography in the evaluation of renal arteries: optimization of technique and pitfalls. J Magn Reson Imaging 2000;12:912-923.
47. Frayne R, Omary RA, Unal O, Strother CM. Determination of optimal injection parameters for intraarterial gadolinium-enhanced MR angiography. J Vasc Interv Radiol 2000;11:1277-1284.
48. Frayne R, Grist TM, Swan JS, Peters DC, Korosec FR, Mistretta CA. 3D MR DSA: effects of injection protocol and image masking. J Magn Reson Imaging 2000;12:476-487.
49. Ruehm SG, Christina H, Violas X, Corot C, Debatin JF. MR angiography with a new rapid-clearance blood pool agent: initial experience in rabbits. Magn Reson Med 2002;48:844-851.
50. Rapp JH, Wolff SD, Quinn SF, et al. Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography-multicenter comparative phase III study. Radiology 2005;236:71-78.
51. Robert P, Violas X, Santus R, Le Bihan D, Corot C. Optimization of a blood pool contrast agent injection protocol for MR angiography. J Magn Reson Imaging 2005;21:611-619.
52. Li W, Tutton S, Vu AT, et al. First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent. J Magn Reson Imaging 2005;21:46-52.
53. Tombach B, Reimer P, Bremer C, et al. First-pass and equilibrium-MRA of the aortolllac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot study. NMR Biomed 2004;17:500-506.
54. Schnorr J, Wagner S, Abramjuk C, et al. Comparison of the iron oxide-based blood-pool contrast medium VSOP-C184 with gadopentetate dimeglumine for first-pass magnetic resonance angiography of the aorta and renal arteries in pigs. Invest Radiol 2004;39:546-553.
55. Paetsch I, Huber ME, Bornstedt A, et al. Improved three-dimensional free-breathing coronary magnetic resonance angiography using gadocoletic acid (B-22956) for intravascular contrast enhancement. J Magn Reson Imaging 2004;20:288-293.
56. Ersoy H, Jacobs P, Kent CK, Prince MR. Blood pool MR angiography of aortic stent-graft endoleak. AJR Am J Roentgenol 2004;182:1181-1186.
57. van Bemmel CM, Wink O, Verdonck B, Viergever MA, Niessen WJ. Blood pool contrast-enhanced MRA: improved arterial visualization in the steady state. IEEE Trans Med Imaging 2003;22:645-652.
58. Schoenberg SO, Nikolaou K. Ultra-high-resolution whole-body MRA using parallel imaging on a 32-channel MR system and blood pool imaging agent: perspectives for clinical applications. Presented at the 16th annual meeting of MRA club, London, Ontario, Canada, 2004:87.
59. Born M, Willinek WA, Gieseke J, von Falkenhausen M, Schild H, Kuhl CK. Sensitivity encoding (SENSE) for contrast-enhanced 3D MR angiography of the abdominal arteries. J Magn Reson Imaging 2005;22:559-565.
60. Schoenberg SO, Knopp MV, Prince MR, Londy F, Knopp MA. Arterial-phase three-dimensional gadolinium magnetic resonance angiography of the renal arteries. Strategies for timing and contrast media injection: original investigation. Invest Radiol 1998;33:506-514.
61. Kopka L, Vosshenrich R, Rodenwaldt J, Grabbe E. Differences in injection rates on contrast-enhanced breath-hold three-dimensional MR angiography. AJR Am J Roentgenol 1998;170:345-348.
62. Boos M, Scheffler K, Haselhorst R, Reese E, Frohlich J, Bongartz GM. Arterial first pass gadolinium-CM dynamics as a function of several intravenous saline flush and Gd volumes. J Magn Reson Imaging 2001;13:568-576.
63. Knopp MV, Giesel FL, von Tengg-Kobligk H, et al. Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine. J Magn Reson Imaging 2003;17:694-702.
64. Krause UJ, Pabst T, Kenn W, Wittenberg G, Hahn D. Time-resolved contrast-enhanced magnetic resonance angiography of the lower extremity. Angiology 2004;55:119-125.
65. Prince MR, Chabra SG, Watts R, et al. Contrast material travel times in patients undergoing peripheral MR angiography. Radiology 2002;224:55-61.
66. Maki JH, Prince MR, Londy FJ, Chenevert TL. The effects of time varying intravascular signal intensity and k-space acquisition order on three-dimensional MR angiography image quality. J Magn Reson Imaging 1996;6:642-651.
67. Sabati M, Lauzon ML, Frayne R. Space-time relationship in continuously moving table method for large FOV peripheral contrast-enhanced magnetic resonance angiography. Phys Med Biol 2003;7:17.
68. Lee JJ, Chang Y, Tirman PJ, et al. Optimizing of gadolinium-enhanced MR angiography by manipulation of acquisition and scan delay times. Eur Radiol 2001;11:754-766.
69. Lee JJ, Chang Y, Kang DS. Contrast-enhanced magnetic resonance angiography: does the test dose bolus represent the main dose bolus accurately. Korean J Radiol 2000;1:91-97.
70. Bae KT. Peak contrast enhancement in CT and MR angiography: when does it occur and why? Pharmacokinetic study in a porcine model. Radiology 2003;227:809-816.
71. Wikstrom J, Johansson L, Karacagil S, Ahlstrom H. The importance of adjusting for differences in proximal and distal contrast bolus arrival times in contrast-enhanced iliac artery magnetic resonance angiography. Eur Radiol 2003;13:957-963.
72. De Marco JK, Schonfeld S, Keller I, Bernstein MA. Contrast-enhanced carotid MR angiography with commercially available triggering mechanisms and elliptic centric phase encoding. AJR Am J Roentgenol 2001;176:221-227.
73. Prince MR, Chenevert TL, Foo TK, Londy FJ, Ward JS, Maki JH. Contrast-enhanced abdominal MR angiography: optimization of imaging delay time by automating the detection of contrast material arrival in the aorta. Radiology 1997;203:109-114.
74. Foo TK, Saranathan M, Prince MR, Chenevert TL. Automated detection of bolus arrival and initiation of data acquisition in fast, three-dimensional, gadolinium-enhanced MR angiography. Radiology 1997;203:275-280.
75. Schoenberg SO, Londy FJ, Licato P, Williams DM, Wakefield T, Chenevert TL. Multiphase-multistep gadolinium-enhanced MR angiography of the abdominal aorta and runoff vessels. Invest Radiol 2001;36:283-291.
76. Riederer SJ, Bernstein MA, Breen JF, et al. Three-dimensional contrast-enhanced MR angiography with real-time fluoroscopic triggering: design specifications and technical reliability in 330 patient studies. Radiology 2000;215:584-593.
77. Luccichenti G, Cademartiri F, Ugolotti U, Marchesi G, Pavone P. Magnetic resonance angiography with elliptical ordering and fluoroscopic triggering of the renal arteries. Radiol Med (Torino) 2003;105:42-47. [Italian]
78. Fain SB, Riederer SJ, Huston Jr, King BF. Embedded MR fluoroscopy: high temporal resolution real-time imaging during high spatial resolution 3D MRA acquisition. Magn Reson Med 2001;46:690-698.
79. Ersoy H, Watts R, Sanelli P, et al. Atherosclerotic disease distribution in carotid and vertebrobasilar arteries: clinical experience in 100 patients undergoing fluoro-triggered 3D Gd-MRA. J Magn Reson Imaging 2003;17:545-558.
80. Butz B, Dorenbeck U, Borisch I, et al. High-resolution contrast-enhanced magnetic resonance angiography of the carotid arteries using fluoroscopic monitoring of contrast arrival: diagnostic accuracy and interobserver variability. Acta Radiol 2004;45:164-170.
81. Carroll TJ, Korosec FR, Petermann GM, Grist TM, Turski PA. Carotid bifurcation: evaluation of time-resolved three-dimensional contrast-enhanced MR angiography. Radiology 2001;220:525-532.
82. Fink C, Bock M, Kiessling F, et al. Time-resolved contrast-enhanced three-dimensional pulmonary MR-angiography: 1.0 M gadobutrol vs. 0.5 M gadopentetate dimeglumine. J Magn Reson Imaging 2004;19:202-208.
83. Golay X, Brown SJ, Itoh R, Melhem ER. Time-resolved contrast-enhanced carotid MR angiography using sensitivity encoding (SENSE). AJNR Am J Neuroradiol 2001;22:1615-1619.
84. Hany TF, Carroll TJ, Omary RA, et al. Aorta and runoff vessels: single-injection MR angiography with automated table movement compared with multiinjection time-resolved MR angiography-initial results. Radiology 2001;221:266-272.
85. Korosec FR, Frayne R, Grist TM, Mistretta CA. Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med 1996;36:345-351.
86. Masunaga H, Takehara Y, Isoda H, et al. Assessment of gadolinium-enhanced time-resolved three-dimensional MR angiography for evaluating renal artery stenosis. AJR Am J Roentgenol 2001;176:1213-1219.
87. Ohno Y, Kawamitsu H, Higashino T, et al. Time-resolved contrast-enhanced pulmonary MR angiography using sensitivity encoding (SENSE). J Magn Reson Imaging 2003;17:330-336.
88. Swan JS, Carroll TJ, Kennell TW, et al. Time-resolved three-dimensional contrast-enhanced MR angiography of the peripheral vessels. Radiology 2002;225:43-52.
89. Volk M, Strotzer M, Lenhart M, et al. Time-resolved contrast-enhanced MR angiography of renal artery stenosis: diagnostic accuracy and interobserver variability. AJR Am J Roentgenol 2000;174:1583-1588.
90. Zhang HL, Khilnani NM, Prince MR, et al. Diagnostic accuracy of time-resolved 2D projection MR angiography for symptomatic infrapopliteal arterial occlusive disease. AJR Am J Roentgenol 2005;184:938-947.
91. Hennig J, Scheffler K, Laubenberger J, Strecker R. Time-resolved projection angiography after bolus injection of contrast agent. Magn Reson Med 1997;37:341-345.
92. Goyen M, Laub G, Ladd ME, et al. Dynamic 3D MR angiography of the pulmonary arteries in under four seconds. J Magn Reson Imaging 2001;13:372-377.
93. Carr JC, Laub G, Zheng J, Pereles FS, Finn JP. Time-resolved three-dimensional pulmonary MR angiography and perfusion imaging with ultrashort repetition time. Acad Radiol 2002;9:1407-1418.
94. Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn Reson Med 1999;42:952-962.
95. Turski PA, Korosec FR, Carroll TJ, Willig DS, Grist TM, Mistretta CA. Contrast-enhanced magnetic resonance angiography of the carotid bifurcation using the time-resolved imaging of contrast kinetics (TRICKS) technique. Top Magn Reson Imaging 2001;12:175-181.
96. Naganawa S, Koshikawa T, Fukatsu H, et al. Contrast-enhanced MR angiography of the carotid artery using 3D time-resolved imaging of contrast kinetics: comparison with real-time fluoroscopic triggered 3D-elliptical centric view ordering. Radiat Med 2001;19:185-192.
97. Du J, Carroll TJ, Wagner HJ, et al. Time-resolved, undersampled projection reconstruction imaging for high-resolution CE-MRA of the distal runoff vessels. Magn Reson Med 2002;48:516-522.
98. Du J, Carroll TJ, Brodsky E, et al. Contrast-enhanced peripheral magnetic resonance angiography using time-resolved vastly undersampled isotropic projection reconstruction. J Magn Reson Imaging 2004;20:894-900.
99. Davis CP, Hany TF, Wildermuth S, Schmidt M, Debatin JF. Postprocessing techniques for gadolinium-enhanced three-dimensional MR angiography. Radiographics 1997;17:1061-1077.
100. Hany TF, Schmidt M, Davis CP, Gohde SC, Debatin JF. Diagnostic impact of four postprocessing techniques in evaluating contrast-enhanced three-dimensional MR angiography. AJR Am J Roentgenol 1998;170:907-912.
101. Persson A, Dahlstrom N, Engellau L, Larsson EM, Brismar TB, Smedby O. Volume rendering compared with maximum intensity projection for magnetic resonance angiography measurements of the abdominal aorta. Acta Radiol 2004;45:453-459.
102. Regenfus M, Ropers D, Achenbach S, et al. Diagnostic value of maximum intensity projections versus source images for assessment of contrast-enhanced three-dimensional breath-hold magnetic resonance coronary angiography. Invest Radiol 2003;38:200-206.
103. Mallouhi A, Schocke M, Judmaier W, et al. 3D MR angiography of renal arteries: comparison of volume rendering and maximum intensity projection algorithms. Radiology 2002;223:509-516.
104. Sueyoshi E, Sakamoto I, Matsuoka Y, Hayashi H, Hayashi K. Symptomatic peripheral vascular tree stenosis. Comparison of subtracted and nonsubtracted 3D contrast-enhanced MR angiography with fat suppression. Acta Radiol 2000;41:133-138.
105. Yamashita Y, Mitsuzaki K, Ogata I, Takahashi M, Hiai Y. Three-dimensional high-resolution dynamic contrast-enhanced MR angiography of the pelvis and lower extremities with use of a phased array coil and subtraction: diagnostic accuracy. J Magn Reson Imaging 1998;8:1066-1072.
106. Hoogeveen RM, Bakker CJ, Viergever MA. MR digital subtraction angiography with asymmetric echo acquisition and complex subtraction: improved lumen and stenosis visualization. Magn Reson Imaging Clin N Am 1999;17:305-311.
107. Ruehm SG, Wiesner W, Debatin JF. Pelvic and lower extremity veins: contrast-enhanced three-dimensional MR venography with a dedicated vascular coil-initial experience. Radiology 2000;215:421-427.
108. Ruehm SG, Zimny K, Debatin JF. Direct contrast-enhanced 3D MR venography. Eur Radiol 2001;11:102-112.
109. Herborn CU, Goyen M, Quick HH, et al. Whole-body 3D MR angiography of patients with peripheral arterial occlusive disease. AJR Am J Roentgenol 2004;182:1427-1434.
110. Herborn CU, Ajaj W, Goyen M, Massing S, Ruehm SG, Debatin JF. Peripheral vasculature: whole-body MR angiography with mid-femoral venous compression-initial experience. Radiology 2004;230:872-878.
111. Hansen T, Wikstrom J, Eriksson MO, et al. Whole-body magnetic resonance angiography of patients using a standard clinical scanner. Eur Radiol 2006;16:147-153.
112. Ruehm SG, Goehde SC, Goyen M. Whole body MR angiography screening. Int J Cardiovasc Imaging 2004;20:587-591.
113. Fenchel M, Requardt M, Tomaschko K, et al. Whole-body MR angiography using a novel 32-receiving-channel MR system with surface coil technology: first clinical experience. J Magn Reson Imaging 2005;21:596-603.
114. Hansen T, Wikstrom J, Eriksson MO, et al. Whole-body magnetic resonance angiography of patients using a standard clinical scanner. Eur Radiol 2005;16:147-153.
115. Nael K, Godinez S, Saleh R, Lee M, Ruehm S, Laub G, Finn JP. Lower extremity MRA with extended field of view: using a 32 channel MR scanner. J Cardiovasc Magn Reson 2006;8:55-56.
116. Herborn CU, Vogt FM, Waltering KU, Reiter KB, Kniemeyer HW, Barkhausen J. Optimization of contrast-enhanced peripheral MR angiography with mid-femoral venous compression (VENCO). Rofo 2004;176:157-162.
117. Prince MR, Zhang HL, Ersoy H, et al. A curved thigh cuff for suppressing venous enhancement on peripheral MRA. In: Proceedings of the 14th Annual Meeting of ISMRM, Seattle, WA, USA. 2006. (Abstract 572)